首页> Alzheimer's & dementia : the journal of the Alzheimer's Association> Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial.

Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial.

导出 OA

翻译打印收藏纠错

第一作者： Joshua D,Grill

第一单位： Institute for Memory Impairments and Neurological Disorder, University of California Irvine, Irvine, Irvine, California, USA.;Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, Irvine, California, USA.;Department of Neurobiology and Behavior, University of California Irvine, Irvine, Irvine, California, USA.

作者： Joshua D,Grill ^[1] ; Rema,Raman ^[2] ; Charlene,Flournoy ^[2] ; Karin,Ernstrom ^[2] ; Aimee,Pierce ^[3] ; Amanda,Smith ^[4] ; Paul,Rosenberg ^[5] ; Jeffrey,Burns ^[6] ; Jason,Karlawish ^[7] ; Paul,Aisen ^[8] ; Karen Chilcott,Holdridge ^[9] ; Michele,Mancini ^[9] ; Reisa,Sperling ^[10] ; David,Sultzer ^[11] ; A4 Study Team

作者单位： Institute for Memory Impairments and Neurological Disorder, University of California Irvine, Irvine, Irvine, California, USA.;Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, Irvine, California, USA.;Department of Neurobiology and Behavior, University of California Irvine, Irvine, Irvine, California, USA. ^[1] Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA. ^[2] Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA. ^[3] Department of Psychiatry and Behavioral Medicine, University of South Florida, Tampa, Florida, USA. ^[4] Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. ^[5] Department of Neurology, University of Kansas Alzheimer's Disease Research Center, Kansas City, Kansas, USA. ^[6] Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. ^[7] Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, Irvine, California, USA. ^[8] Eli Lilly and Company, Indianapolis, Indiana, USA. ^[9] Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. ^[10] Institute for Memory Impairments and Neurological Disorder, University of California Irvine, Irvine, Irvine, California, USA.;Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, Irvine, California, USA. ^[11]

关键词 biomarker disclosure preclinical suicide